ArticleJournal of pancreatic cancer2018

Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors.

Muhammad Wasif Saif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.